At QxP Pharma Consultants & GMP Services we offer comprehensive, customized solutions to identify and resolve compliance gaps, enabling you to meet stringent global quality standards, including FDA, EU GMP, and WHO GMP.
As one of the leading Pharma Consultants in India, we specialize in preparing facilities across the country through GMP Compliance Gap Assessments, Mock Audits, and QMS Gap Analysis, helping clients move confidently toward regulatory approval.
Why Pharma Site Gap Assessment Audit is Critical?
Modern pharmaceutical manufacturing is governed by Good Manufacturing Practices (GMP) and GxP (Good Practice) standards.
Any deviation or gap in compliance can result in costly delays, warning letters, or product recalls. That’s where Site Gap Assessment Audits come into play.
A well-structured Pre-Audit Gap Assessment for Pharma Plants:
Identifies regulatory non-conformances before actual inspections
Minimizes the risk of audit failures
Helps build a culture of continuous quality improvement
Ensures smooth Regulatory Submissions and Approvals
Whether your facility is gearing up for an FDA Inspection, EU GMP inspection, or an internal corporate audit, QxP’s services offer a strategic advantage.
About QxP Pharma Consultants in Ahmedabad
With headquarters in Ahmedabad, QxP Pharma Consultants & GMP Services are among the top GMP Services Providing in Ahmedabad and GMP Services Providing in India.
Our specialists bring decades of collective experience from regulatory bodies and the pharmaceutical industry, offering unrivaled expertise in:
Comprehensive GMP Site Audit Services
Regulatory Gap Assessments for Pharma Facilities
Manufacturing Site Gap Assessment Solutions
QMS Gap Assessment and Remediation Planning
Our team follows a structured, audit-based methodology that is adaptable across dosage forms, including oral solids, injectables, biologics, APIs, and sterile products.
Our Site Gap Assessment Audit Approach
1. Pre-Audit Planning and Kick-off
We begin by understanding the scope of operations, compliance history, and regulatory goals. A project plan is shared outlining timelines, documents needed, and audit checklists.
2. On-Site Inspection and Documentation Review
Our auditors conduct a GMP-focused review of:
Quality Management Systems
Production & Process Controls
Facilities & Equipment
Laboratory Controls
Data Integrity Compliance
Risk Management Programs
This phase also includes Mock Audit and Gap Identification Services, simulating a real-time inspection experience.
3. Gap Identification and Risk Ranking
All findings are documented and categorized by criticality:
Critical Gaps – Immediate risk to product quality or patient safety
Major Gaps – Significant deviations from GMP standards
Minor Gaps – Areas for improvement
This enables management to prioritize actions with full visibility.
4. QMS Gap Assessment and Remediation Planning
Our team collaborates with your staff to:
Develop Corrective and Preventive Action (CAPA) plans
Redesign SOPs where needed
Train personnel for audit readiness
Implement quality improvements
We also assist in GxP Site Readiness Audits to verify the effectiveness of remediation activities.
Key Features of Our Site Gap Assessment Services
FDA Inspection Gap Assessment: Our auditors simulate FDA audit expectations, flagging issues that could result in 483 observations or warning letters.
EU GMP Site Gap Audit Experts: With deep knowledge of EMA expectations, our consultants tailor audits for EU GMP certification, a must for exports to the EU.
Mock Audit and Gap Identification Services: Experience a realistic regulatory inspection scenario, preparing your team to respond effectively.
Quality System Gap Assessment
: We assess the robustness of your Quality Management System (QMS) and ensure it aligns with ICH Q10, ISO 9001, and other global standards.
Site Gap Analysis for Regulatory Compliance: Detailed checklists aligned with 21 CFR Part 210/211, EU Annexes, Schedule M, and WHO TRS ensure complete regulatory mapping.
Who Needs Site Gap Assessment Audit Services?
New Pharma Manufacturing Facilities preparing for GMP licensing
Existing Sites planning for FDA, MHRA, TGA, or WHO inspections
Facilities Upgrading infrastructure or equipment
CDMOs and CMOs aiming to ensure compliance across multiple client requirements
Global Pharma Companies managing multi-site compliance from India
Why Choose QxP Pharma Consultants?
Proven Track Record: Trusted by leading pharma and biotech firms across India and globally.
Customized Audits: We align assessments to your operational scope, dosage form, and target market.
Based in Ahmedabad, Serving All of India: We are strategically positioned among the best GMP Services Providing in Ahmedabad and GMP Services Providing in India.
End-to-End Solutions: From gap assessment to CAPA closure and re-audits, we provide audit-ready site compliance services.
Frequently Asked Questions (FAQs)
Q1: What is a site gap assessment audit in pharma and why do manufacturing companies in India need it before a regulatory inspection?
A site gap assessment audit in India a structured evaluation of your pharma facility against applicable GMP standards like Schedule M, WHO-GMP, or EU-GMP to identify compliance gaps before a regulatory inspection. Every pharmaceutical manufacturing company in India needs it to find and fix weaknesses in SOPs, documentation, facility design, and quality systems before CDSCO, USFDA, or MHRA auditors arrive. It saves you from critical observations and potential plant shutdowns.
Q2: How does a site gap assessment audit help a pharma plant in Gujarat or Maharashtra prepare for WHO-GMP or EU-GMP certification?
A site gap assessment audit compares your current facility condition, documentation status, and quality management systems directly against WHO-GMP or EU-GMP requirements. For pharma plants in Gujarat and Maharashtra, this audit creates a clear gap report with prioritized action points. Your team then closes each gap before the actual certification inspection arrives. This structured approach significantly increases your first-attempt success rate and reduces costly re-inspection fees and timeline delays.
Q3: What areas does a GMP site gap assessment audit cover at a pharmaceutical manufacturing unit in Ahmedabad or Pune?
A GMP site gap assessment audit at pharma manufacturing units in Ahmedabad and Pune covers facility layout, HVAC validation, water system qualification, equipment calibration, cleaning validation, SOP documentation, batch record review, data integrity systems, warehouse controls, and quality management systems. Auditors also check personnel hygiene practices, pest control records, and deviation management. Every area gets evaluated against Schedule M and applicable international GMP guidelines to produce a complete gap report.
Q4: What is the difference between a site gap assessment audit and a mock inspection for a pharma company preparing for USFDA or CDSCO audit in India?
A site gap assessment audit identifies compliance gaps against specific GMP standards and gives you a structured remediation plan. A mock inspection simulates the actual regulator behavior and tests how your team responds under pressure. For pharma companies in India preparing for USFDA or CDSCO audits, experts recommend conducting a site gap assessment first, fixing all identified gaps, and then running a mock inspection to validate your readiness before the real regulatory visit.
Q5: How long does a site gap assessment audit take for a mid-size pharmaceutical plant in Rajasthan or Madhya Pradesh?
A site gap assessment audit for a mid-size pharmaceutical plant in Rajasthan or Madhya Pradesh typically takes 2 to 4 working days on-site depending on the number of dosage forms, manufacturing areas, and applicable GMP regulations. After the on-site visit, the consultant delivers a detailed gap assessment report within 5 to 7 working days. The report includes critical, major, and minor gaps with clear CAPA timelines so your team starts remediation immediately without confusion.
Q6: Which pharma GMP consultant in India provides site gap assessment audit services for Schedule M and WHO-GMP compliance?
QXP Pharma Project Consultant & GMP Service Pvt. Ltd. provides expert site gap assessment audit services for pharmaceutical companies across India against Schedule M, WHO-GMP, EU-GMP, and USFDA standards. Their experienced auditors assess your entire facility, document every compliance gap, and deliver a prioritized CAPA-based remediation plan. Companies in Gujarat, Maharashtra, Rajasthan, and Madhya Pradesh regularly engage them before major regulatory inspections to ensure strong GMP compliance readiness.
Q7: What common GMP gaps do pharma companies in India discover during a site gap assessment audit before regulatory inspections?
During a site gap assessment audit, pharma companies in India most commonly discover gaps in data integrity controls, cleaning validation protocols, HVAC qualification records, SOP version management, change control documentation, and equipment calibration logs. Contact QXP Pharma Project Consultant & GMP Service Pvt. Ltd. finds that many facilities also lack proper deviation investigation and CAPA closure systems. Identifying these gaps early gives your team enough time to implement fixes before CDSCO, WHO, or USFDA inspectors conduct the actual regulatory audit.
Let’s Make Your Facility Audit-Ready
The regulatory landscape is evolving. Don’t wait for an inspection to reveal compliance problems.
Let Pharma Consultants in India help you become inspection-ready through expert Site Gap Assessment Audit Services.
Whether you’re targeting local licenses or international markets, our Comprehensive GMP Site Audit Services are designed to give you a competitive edge.